Clinical trials
Treatment Outcome clinical trials
Below are recruiting treatment outcome clinical trials, each written for real people, not researchers. We’re tracking 286 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07457554Recruiting
Can respiratory quotient help ICU patients on ventilators?
This study looks at whether using a simple measurement called the respiratory quotient (a sign of how your body is using fuel) can help doctors make better decisions for patients on a breathing machine in the ICU. It may lead to safer, more personalized care.
Poznan, WielkopolskaAges 18–85 - NCT03845205Recruiting
Liver transplant timing study for alcohol-related liver disease
This study compares early versus standard liver transplant timing for people whose liver illness was caused by alcohol use. It looks at treatment outcomes to see which approach helps patients do better.
Baltimore, MarylandAges 18 years+ - NCT07752498Enrolling by invitation
Long-term results from twin block treatment
This study checks whether the results from an earlier treatment with the Twin Block appliance, which corrects bite problems, hold up over time. It looks at how stable the teeth and jaw remain years after treatment.
Jönköping, Jönköping CountyAges Any age - NCT07452614Recruiting
Predicting pulp treatment success with metabolic markers
This trial tests if a metabolic biomarker can predict how well a vital pulp treatment works for tooth pain caused by deep cavities. It aims to help patients keep their natural teeth instead of needing root canals.
BaghdadAges 16–50 - NCT07057765Recruiting
Blood markers for predicting DLBCL treatment response
This study looks at how certain blood tests (like CRP, albumin, and their ratios) might help predict how well treatment works for newly diagnosed DLBCL. If you are getting R-CHOP, this trial could help doctors better understand your response to therapy.
Cairo, Cairo GovernorateAges 18–65 - NCT07051850Recruiting
Quality of life study for relapsed myeloma immunotherapy
This study compares quality of life and treatment results in people with relapsed or refractory multiple myeloma who receive either newer or standard immunotherapy. It aims to understand how these treatments affect daily living and outcomes.
Seocho, SeoulAges 19 years+ - NCT06805721Recruiting
Observational study of endovascular treatment for brain and spine vessel conditions
This study follows patients of any age who are having a minimally invasive procedure (endovascular treatment) for blood vessel problems in the brain or spine. It looks at how patients do before and after the procedure, any complications, and what factors might predict a good outcome.
MilanAges Any age - NCT07413068Recruiting
Comparing treatments for gallstones and bile duct stones
This trial looks at three different ways to treat people who have both gallstones and stones in the bile duct. It aims to find which approach works best and with the fewest complications.
Jinan, ShandongAges 18 years+ - NCT06367829Enrolling by invitation
Hip replacement study with Lubinus SPII stem
This study looks at how well the Lubinus SPII hip stem works in people who need a hip replacement due to osteoarthritis, a hip fracture, or bone death. It may help doctors understand which patients do best with this implant.
Amsterdam, North HollandAges 5–105 - NCT06873009Enrolling by invitation
Can therapy help men in prison quit smoking?
This trial tests if cognitive behavioural therapy (a type of talk therapy that changes thinking and habits) can help men in prison stop smoking. It aims to see what works best and for whom.
Paris, Île-de-France RegionAges 18 years+ - NCT05902221RecruitingPhase 3
Rifampicin add-on for knee, hip, or shoulder implant infections
This Phase 3 trial tests whether adding rifampicin improves outcomes for implant infections caused by a specific germ (Cutibacterium acnes) after surgery. If you have such an infection and the germ is susceptible, you may be able to receive a rifampicin-based treatment plan.
AnnecyAges 18 years+ - NCT06680401Recruiting
EHE: An Observational Study for People With This Rare Tumor
This study is tracking people with a rare blood vessel tumor called epithelioid hemangioendothelioma (EHE) to learn more about how it behaves and how best to care for you. By joining, you'll help doctors improve future treatments for this condition.
MilanAges 18 years+ - NCT06966141Recruiting
Real-World Study of Sacituzumab Govitecan for Breast Cancer
This study looks at how well the drug Sacituzumab Govitecan works in real-life settings for people with certain types of advanced breast cancer that have not responded to prior treatments.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07387601Recruiting
Peer education for TB treatment in Ethiopia
This trial tests whether having a peer educator (someone who has been through TB treatment) help you stay on track with your medicines and get better. It is for adults with new, easy-to-treat TB in South Omo and Ari Zone, Ethiopia.
Jinka, Southern EthiopiaAges 18 years+ - NCT07243379RecruitingPhase 4
Studying nanocrystalline megestrol acetate for weight loss in cancer
This study tests a special form of the drug megestrol acetate (Megace) in cancer patients who have lost weight and appetite (cachexia). It aims to see if this medication can help improve weight gain and quality of life.
Zhengzhou, HenanAges 18–85 - NCT07288840Enrolling by invitation
Exercise plan for heart recovery monitored by heart rate
This study tests a special exercise program for people with heart disease or heart failure. The goal is to see if the exercises can help improve how your heart responds to activity and daily life.
Leiria, Leiria DistrictAges 18 years+ - NCT07430306RecruitingPhase 3
Study of anifrolumab for lupus patients not yet on strong treatments
This trial tests if a new drug called anifrolumab can help treat lupus in people who haven't taken strong medications like biologics or immunosuppressants before. It looks at overall disease activity and the chance to reduce steroid use.
Anniston, AlabamaAges 18–70 - NCT07377747Recruiting
Study of treatment for recurrent retroperitoneal liposarcoma
This study looks at how well standard treatments work for people whose liposarcoma has come back in the same area. It helps doctors understand best ways to manage this rare cancer.
Atlanta, GeorgiaAges 18 years+ - NCT03237026Recruiting
Urine tests to predict outcomes in prostate cancer treatment
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
TaipeiAges 30–100 - NCT04432883Recruiting
Brain stimulation to improve speech after stroke aphasia
This trial tests whether targeted mild brain stimulation (tDCS) can improve speech therapy results for people with long-lasting (chronic) aphasia after a stroke. It may help strengthen naming and communication when added to standard speech-language treatment.
Albuquerque, New MexicoAges 25–85 - NCT04525833Recruiting
Visit Tzu Chi gastroenterology clinic study
This study looks at people who have visited a Tzu Chi Hospital gastroenterology clinic. It may help researchers understand liver and other whole-body health conditions in patients who receive care there.
New Taipei CityAges 18–99 - NCT04567030Recruiting
AI tool to help improve gum treatment outcomes
This trial tests whether an artificial intelligence (AI) system can help plan and improve results of gum (periodontal) treatment. You may be a good match if you have diagnosed periodontal disease and enough healthy teeth.
Kaohsiung CityAges 35–65 - NCT05035511Recruiting
Predicting tDCS results in autistic teens with machine learning
This study uses machine learning to predict how well a teen with autism may respond to tDCS, a non-invasive brain stimulation. It mainly looks at personal factors (like understanding instructions and baseline abilities) to better estimate treatment outcomes.
Hung Hom, KowloonAges 12–22 - NCT05339789Recruiting
Annual follow-up after surgery for implant gum disease
This trial follows people who had surgery for gum inflammation around a dental implant and checks their results over the long term. It may help by improving how clinicians monitor healing and prevent implant problems after surgery.
ViennaAges 18–130
Hear when a new Treatment Outcome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment outcome?
- Yes. Clin2 currently lists 286 recruiting treatment outcome studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment outcome trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment outcome trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.